Conte G, Fuiano G, Sabbatini M, Terribile M, Federico S, Russo D, Dal Canton A
Department of Nephrology, Second Faculty of Medicine, University of Naples, Italy.
Nephron. 1988;50(4):299-305. doi: 10.1159/000185192.
To assess the intrinsic effects of treatment with furosemide on free-water excretion in patients with chronic renal failure, two groups of patients with and without replacement of diuretic-induced salt losses have been studied. Furosemide therapy was administered for 1 week during constant sodium intake (100 mEq/day). In neither of the groups did furosemide cause hyponatremia, while it did decrease the urine to plasma osmolality ratio, an effect lasting even when the diuretic effect was exhausted. During water diuresis, furosemide decreased the fractional sodium reabsorption in diluting segments but not the absolute rate of the free-water generation (CH2O). Presumably the expected decrease of CH2O was masked by the increased distal delivery of tubular fluid mainly due to an additional effect of the diuretic on the proximal tubule. The hypotonicity of urine after furosemide treatment may be secondary to the dissipation of medullary hypertonicity, caused by furosemide, in the condition of decreased water permeability of the collecting duct due to uremic disease.
为评估呋塞米治疗对慢性肾衰竭患者自由水排泄的内在影响,我们研究了两组分别有和没有补充利尿剂引起的盐分丢失的患者。在恒定钠摄入量(100 mEq/天)的情况下,给予呋塞米治疗1周。两组中呋塞米均未导致低钠血症,但它确实降低了尿渗透压与血浆渗透压之比,即使利尿作用消失,这种作用仍持续存在。在水利尿期间,呋塞米降低了稀释段的钠重吸收分数,但未降低自由水生成的绝对速率(CH2O)。推测预期的CH2O降低被肾小管液远端输送增加所掩盖,这主要是由于利尿剂对近端小管的额外作用。呋塞米治疗后尿液的低渗可能继发于由于尿毒症疾病导致集合管水通透性降低的情况下,呋塞米引起的髓质高渗的消散。